These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

152 related items for PubMed ID: 28725681

  • 1. Comparison of clinical features in pathologically confirmed PSP and MSA patients followed at a tertiary center.
    Xie T, Kang UJ, Kuo SH, Poulopoulos M, Greene P, Fahn S.
    NPJ Parkinsons Dis; 2015; 1():15007. PubMed ID: 28725681
    [Abstract] [Full Text] [Related]

  • 2. Early clinical features of patients with progressive supranuclear palsy with predominant cerebellar ataxia.
    Kanazawa M, Tada M, Onodera O, Takahashi H, Nishizawa M, Shimohata T.
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1149-51. PubMed ID: 23916652
    [Abstract] [Full Text] [Related]

  • 3. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy.
    O'Sullivan SS, Massey LA, Williams DR, Silveira-Moriyama L, Kempster PA, Holton JL, Revesz T, Lees AJ.
    Brain; 2008 May; 131(Pt 5):1362-72. PubMed ID: 18385183
    [Abstract] [Full Text] [Related]

  • 4. Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders? A clinicopathological study.
    Litvan I, Campbell G, Mangone CA, Verny M, McKee A, Chaudhuri KR, Jellinger K, Pearce RK, D'Olhaberriague L.
    Brain; 1997 Jan; 120 ( Pt 1)():65-74. PubMed ID: 9055798
    [Abstract] [Full Text] [Related]

  • 5. Predictors of survival in progressive supranuclear palsy and multiple system atrophy: a systematic review and meta-analysis.
    Glasmacher SA, Leigh PN, Saha RA.
    J Neurol Neurosurg Psychiatry; 2017 May; 88(5):402-411. PubMed ID: 28250027
    [Abstract] [Full Text] [Related]

  • 6. Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy.
    Testa D, Monza D, Ferrarini M, Soliveri P, Girotti F, Filippini G.
    Neurol Sci; 2001 Jun; 22(3):247-51. PubMed ID: 11731878
    [Abstract] [Full Text] [Related]

  • 7. Montreal Cognitive Assessment (MoCA) and Mini-Mental State Examination (MMSE) performance in progressive supranuclear palsy and multiple system atrophy.
    Fiorenzato E, Weis L, Falup-Pecurariu C, Diaconu S, Siri C, Reali E, Pezzoli G, Bisiacchi P, Antonini A, Biundo R.
    J Neural Transm (Vienna); 2016 Dec; 123(12):1435-1442. PubMed ID: 27334897
    [Abstract] [Full Text] [Related]

  • 8. Clinical features and disability milestones in multiple system atrophy and progressive supranuclear palsy.
    Lee SW, Koh SB.
    J Mov Disord; 2012 Oct; 5(2):42-7. PubMed ID: 24868413
    [Abstract] [Full Text] [Related]

  • 9. Progressive Supranuclear Palsy with Predominant Cerebellar Ataxia.
    Ando S, Kanazawa M, Onodera O.
    J Mov Disord; 2020 Jan; 13(1):20-26. PubMed ID: 31847511
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Apraxia in Parkinson's disease, progressive supranuclear palsy, multiple system atrophy and neuroleptic-induced parkinsonism.
    Leiguarda RC, Pramstaller PP, Merello M, Starkstein S, Lees AJ, Marsden CD.
    Brain; 1997 Jan; 120 ( Pt 1)():75-90. PubMed ID: 9055799
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Neurogenic bladder in progressive supranuclear palsy: A comparison with Parkinson's disease and multiple system atrophy.
    Kim KJ, Jeong SJ, Kim JM.
    Neurourol Urodyn; 2018 Jun; 37(5):1724-1730. PubMed ID: 29356135
    [Abstract] [Full Text] [Related]

  • 16. Clinical Milestones Preceding the Diagnosis of Multiple System Atrophy and Progressive Supranuclear Palsy: A Retrospective Cohort Study.
    Wiblin L, Durcan R, Galna B, Lee M, Burn D.
    J Mov Disord; 2019 Sep; 12(3):177-183. PubMed ID: 31390854
    [Abstract] [Full Text] [Related]

  • 17. Coexistence of PSP and MSA: a case report and review of the literature.
    Uchikado H, DelleDonne A, Uitti R, Dickson DW.
    Acta Neuropathol; 2006 Feb; 111(2):186-92. PubMed ID: 16456665
    [Abstract] [Full Text] [Related]

  • 18. Incidence of progressive supranuclear palsy and multiple system atrophy in Olmsted County, Minnesota, 1976 to 1990.
    Bower JH, Maraganore DM, McDonnell SK, Rocca WA.
    Neurology; 1997 Nov; 49(5):1284-8. PubMed ID: 9371909
    [Abstract] [Full Text] [Related]

  • 19. [Iodine 123-labeled meta-iodobenzylguanidine myocardial scintigraphy in the cases of idiopathic Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy].
    Yoshita M, Hayashi M, Hirai S.
    Rinsho Shinkeigaku; 1997 Jun; 37(6):476-82. PubMed ID: 9366173
    [Abstract] [Full Text] [Related]

  • 20. PSP as distinguished from CBD, MSA-P and PD by clinical and imaging differences at an early stage.
    Kurata T, Kametaka S, Ohta Y, Morimoto N, Deguchi S, Deguchi K, Ikeda Y, Takao Y, Ohta T, Manabe Y, Sato S, Abe K.
    Intern Med; 2011 Jun; 50(22):2775-81. PubMed ID: 22082889
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.